IHH Healthcare Unit Seeks Up to INR109 Billion in Damages from Daiichi Sankyo

MT Newswires

2025/05/21

IHH Healthcare's (SGX:Q0F, KLSE:IHH) indirect subsidiary, Northern TK Venture (NTK), applied to the Tokyo District Court to revise the damages sought from Daiichi Sankyo (TYO:4568) over the botched Fortis Healthcare stake acquisition, according to a Tuesday filing with SGX.

NTK is now pursuing up to 109.3 billion Indian rupees, or almost 184 billion yen, in damages, citing losses from the aborted deal. The subsidiary alleges the Japanese drugmaker caused financial harm by obstructing its open offer to acquire a larger stake in the Indian hospital chain in 2018.

NTK first filed a claim in October 2023 to seek damages of 20 billion yen or 11.9 billion rupees from Daiichi for stopping its efforts to complete the open offer.

IHH acquired a 31% stake in Fortis through NTK. However, it suspended its open offer to purchase an additional 26% after Daiichi Sankyo filed a contempt plea against Fortis's founders.

In addition to the revised damages, NTK is also seeking 2.7 million rupees for losses linked to a defamation claim against Daiichi Sankyo, along with accrued interest on total damages claimed.

The next hearing of the case has been scheduled for July 11, the filing stated.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2537672557"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537672557\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537672557?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-21 12:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537672557","market":"sg","top_or_hot":-1,"title":"IHH Healthcare Unit Seeks Up to INR109 Billion in Damages from Daiichi Sankyo","media":"MT Newswires","content":"<html><body><p> IHH Healthcare's (SGX:Q0F, KLSE:IHH) indirect subsidiary, Northern TK Venture (NTK), applied to the Tokyo District Court to revise the damages sought from Daiichi Sankyo (TYO:4568) over the botched Fortis Healthcare stake acquisition, according to a Tuesday filing with SGX.</p><p>NTK is now pursuing up to 109.3 billion Indian rupees, or almost 184 billion yen, in damages, citing losses from the aborted deal. The subsidiary alleges the Japanese drugmaker caused financial harm by obstructing its open offer to acquire a larger stake in the Indian hospital chain in 2018.</p><p>NTK first filed a claim in October 2023 to seek damages of 20 billion yen or 11.9 billion rupees from Daiichi for stopping its efforts to complete the open offer.</p><p>IHH acquired a 31% stake in Fortis through NTK. However, it suspended its open offer to purchase an additional 26% after Daiichi Sankyo filed a contempt plea against Fortis's founders.</p><p>In addition to the revised damages, NTK is also seeking 2.7 million rupees for losses linked to a defamation claim against Daiichi Sankyo, along with accrued interest on total damages claimed.</p><p>The next hearing of the case has been scheduled for July 11, the filing stated.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Unit Seeks Up to INR109 Billion in Damages from Daiichi Sankyo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Unit Seeks Up to INR109 Billion in Damages from Daiichi Sankyo\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time smaller\">2025-05-21 12:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> IHH Healthcare's (SGX:Q0F, KLSE:IHH) indirect subsidiary, Northern TK Venture (NTK), applied to the Tokyo District Court to revise the damages sought from Daiichi Sankyo (TYO:4568) over the botched Fortis Healthcare stake acquisition, according to a Tuesday filing with SGX.</p><p>NTK is now pursuing up to 109.3 billion Indian rupees, or almost 184 billion yen, in damages, citing losses from the aborted deal. The subsidiary alleges the Japanese drugmaker caused financial harm by obstructing its open offer to acquire a larger stake in the Indian hospital chain in 2018.</p><p>NTK first filed a claim in October 2023 to seek damages of 20 billion yen or 11.9 billion rupees from Daiichi for stopping its efforts to complete the open offer.</p><p>IHH acquired a 31% stake in Fortis through NTK. However, it suspended its open offer to purchase an additional 26% after Daiichi Sankyo filed a contempt plea against Fortis's founders.</p><p>In addition to the revised damages, NTK is also seeking 2.7 million rupees for losses linked to a defamation claim against Daiichi Sankyo, along with accrued interest on total damages claimed.</p><p>The next hearing of the case has been scheduled for July 11, the filing stated.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"Q0F.SI","symbol_name":"IHH醫療保健集團","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2537672557","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537672557","pubTimestamp":1747801476,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"IHH Healthcare's  indirect subsidiary, Northern TK Venture , applied to the Tokyo District Court to revise the damages sought from Daiichi Sankyo  over the botched Fortis Healthcare stake acquisition, according to a Tuesday filing with SGX.NTK is now pursuing up to 109.3 billion Indian rupees, or almost 184 billion yen, in damages, citing losses from the aborted deal. The subsidiary alleges the Japanese drugmaker caused financial harm by obstructing its open offer to acquire a larger stake in the Indian hospital chain in 2018.NTK first filed a claim in October 2023 to seek damages of 20 billion yen or 11.9 billion rupees from Daiichi for stopping its efforts to complete the open offer.IHH acquired a 31% stake in Fortis through NTK. However, it suspended its open offer to purchase an additional 26% after Daiichi Sankyo filed a contempt plea against Fortis's founders.In addition to the revised damages, NTK is also seeking 2.7 million rupees for losses linked to a defamation claim against","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"Q0F.SI":"IHH医疗保健集团","BK6511":"医疗保健服务概念","BK6092":"保健护理机构"},"translate_title":"IHH医疗保健部门向第一三共寻求高达1090亿印度卢比的赔偿","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"Q0F.SI":0.9},"content_text":"IHH Healthcare's (SGX:Q0F, KLSE:IHH) indirect subsidiary, Northern TK Venture (NTK), applied to the Tokyo District Court to revise the damages sought from Daiichi Sankyo (TYO:4568) over the botched Fortis Healthcare stake acquisition, according to a Tuesday filing with SGX.NTK is now pursuing up to 109.3 billion Indian rupees, or almost 184 billion yen, in damages, citing losses from the aborted deal. The subsidiary alleges the Japanese drugmaker caused financial harm by obstructing its open offer to acquire a larger stake in the Indian hospital chain in 2018.NTK first filed a claim in October 2023 to seek damages of 20 billion yen or 11.9 billion rupees from Daiichi for stopping its efforts to complete the open offer.IHH acquired a 31% stake in Fortis through NTK. However, it suspended its open offer to purchase an additional 26% after Daiichi Sankyo filed a contempt plea against Fortis's founders.In addition to the revised damages, NTK is also seeking 2.7 million rupees for losses linked to a defamation claim against Daiichi Sankyo, along with accrued interest on total damages claimed.The next hearing of the case has been scheduled for July 11, the filing stated.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}